Beximco Pharmaceuticals Limited (AIM:BXP)
London
· Delayed Price · Currency is GBP · Price in GBX 36.00
+1.58 (4.39%)
May 13, 2025, 4:35 PM GMT+1
Beximco Pharmaceuticals Market Cap
Beximco Pharmaceuticals has a market cap or net worth of 250.94 million as of May 13, 2025. Its market cap has decreased by -31.85% in one year.
Market Cap
250.94M
Enterprise Value
296.27M
Revenue
309.11M
Ranking
n/a
PE Ratio
5.92
Stock Price
36.00
Market Cap Chart
Since January 3, 2000, Beximco Pharmaceuticals's market cap has increased from 22.96M to 250.94M, an increase of 992.84%. That is a compound annual growth rate of 9.88%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 158.79B |
| GSK plc | 55.98B |
| Haleon | 36.67B |
| Smith & Nephew | 9.35B |
| ConvaTec Group | 5.26B |
| Hikma Pharmaceuticals | 4.42B |
| HUTCHMED (China) | 1.95B |
| Genus | 1.39B |